INVESTORS TITLE CO
$254.39
+2.80 (+1.11%) · delayed · Nov 13, 2026
Five-year price
52w $209.75 to $309.55
- Market cap
- $480M
- Enterprise value
- $460M
- P/E
- 13.7×
- 16.4× on 3y avg EPS
- EV / EBIT
- —
- FCF yield
- 5.3%
- ROIC
- —
- Debt / equity
- —
- Piotroski F
- 6/9
Value scorecard · FY2025
Does it pass the value tests?
Quality
50
- –ROIC > 12% (5y avg)5y avg ROIC n/a
- ○ROE > 15% (5y avg)5y avg ROE 14.6%
- –Stable operating marginsMargin volatility n/a (σ, 5y)
- ○Earnings convert to cashFCF / net income 66% (5y avg)
- ●Growing revenueRevenue CAGR 5y 19.2%
- ●Shrinking share countDiluted shares -0.1% over 5y
Value
50
- ●P/E below 15P/E 13.7
- –EV/EBIT below 12EV/EBIT n/a
- ○FCF yield above 6%FCF yield 5.3%
- ○Price below Graham NumberGraham Number $243.63
- ●P/B below 3P/B 1.8
Safety
n/a
- –Debt / equity below 0.5D/E n/a
- ●Debt payable in < 4 yrs of earningsNet debt $-0.0B
- –Interest coverage > 8xCoverage n/ax
- –Current ratio > 1.5Current ratio n/a
- ●Piotroski F-score ≥ 6F-score 6/9
Graham Defensive
33
- ○Adequate size (revenue > $2B)Revenue $0.0B
- –Strong condition (current ratio ≥ 2)Current ratio n/a
- ●Earnings stability (no loss, 10y)10 years of data
- ●Uninterrupted dividendsDividends paid every year on record
- ○Earnings growth ≥ 33% (10y, 3y avgs)EPS growth 32%
- ○Moderate P/E (≤ 15 on 3y avg EPS)P/E (3y avg) 16.4
- ○P/E × P/B ≤ 22.5Product 29.4
Valuation lab
What do you have to believe?
At $254.39, the market is pricing in about 4.3% annual free-cash-flow growth for the next decade (9% discount rate, 2.5% terminal growth).
Starting cash flow
Net debt −$21M · 2M shares · 5y revenue CAGR 19.2%
Intrinsic value
$745.60
Price
$254.39
Margin of safety
66%
What the price implies
The market is paying for 4.3% annual cash-flow growth for 10 years at a 9.0% discount rate.
Terminal value share
69% of the value sits beyond year 10.
Financial statements
A decade of the record.
USD millions · fiscal years · source: SEC 10-K XBRL
| Line item | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 13 | 14 | 17 | 17 | 23 | 36 | 36 | 35 | 41 |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — |
| Pre-tax income | 28 | 30 | 27 | 40 | 50 | 85 | 30 | 26 | 39 | 45 |
| Income tax | 9 | 5 | 5 | 8 | 10 | 18 | 6 | 5 | 8 | 9 |
| Net income | 20 | 26 | 22 | 31 | 39 | 67 | 24 | 22 | 31 | 35 |
| EPS (diluted) | 10.19 | 13.56 | 11.54 | 16.59 | 20.80 | 35.28 | 12.59 | 11.45 | 16.43 | 18.57 |
| Diluted shares | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Who owns it